Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tonglin Capsule is a Traditional Chinese Medicine (TCM) formulation developed by the Henan Provincial Institute of Medical Science and manufactured by companies such as Henan Fusen Pharmaceutical. It is primarily indicated for the treatment of chronic lower urinary tract infections, including cystitis and urethritis, as well as chronic prostatitis. The capsule is composed of a complex blend of herbal extracts, including *Herba Dianthi*, *Herba Polygoni Avicularis*, *Herba Plantaginis*, *Radix et Rhizoma Rhei*, and *Fructus Gardeniae*. These ingredients are traditionally used in TCM to clear heat, detoxify, and promote diuresis. Pharmacological studies indicate that the formulation possesses broad-spectrum antibacterial activity against common uropathogens like *Escherichia coli* and *Staphylococcus aureus*, while also exerting anti-inflammatory effects by inhibiting the production of inflammatory mediators. It is widely utilized in clinical practice in China to alleviate symptoms such as dysuria, urinary frequency, and urgency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tonglin Capsule.